Sanofi Drops Maze Licensing Deal After FTC Challenge | Goodwin
The FTC announced yesterday that it would seek to block Sanofi’s proposed exclusive license agreement with Maze Therapeutics, having concluded that the transaction would “eliminate a...
Genyzme Corporation M Maze Partnership Maze Therapeutics While Sanofi Block Sanofi Rare Disease Drug
Source: jdsupra.com